Any transient insult for the myocardium will result in an acute biomarker launch—depending on the circumstance, this is likely to be an acute on Serious release when there are other aspects contributing to myocardial pressure. Figure threeIf cardiac troponin assays will not be readily available, the ideal choice is CK-MB measurement (preferably